Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06904144 · ClinicalTrials.gov registry record · NA

Health Coaching for Patients With Cardiovascular Disease

A NA study, sponsored by Ohio State University.

Not yet
Registry status
NA
Development phase
70
Enrollment target

NCT06904144: Clinical Trial NA study, sponsored by Ohio State University.

NCT06904144 is a NA study that has not yet begun recruiting, run by Ohio State University. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06904144, a NA study, has not yet begun recruiting, sponsored by Ohio State University.

NOT YET RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target

Study Summary

For patients discharged with a diagnosis of cardiovascular disease coronary artery disease resulting in myocardial infarction and/or congestive heart failure, this study will evaluate if the addition of 12 virtual health coaching sessions over the course of 16 weeks will improve physiological, psychological, and social health outcomes, prove acceptable and satisfactory for these patients with CVD, decrease CVD-related questions and concerns sent to the provider via MyChart, and reduce hospital readmission rates over a 90-day period as compared to patients discharged with the same diagnosis who receive standard post-discharge care. The study will also evaluate the perceptions of physician and advanced practice providers related to the health coach as part of the interprofessional team and the amount of time spent addressing CVD-related patient questions and concerns via MyChart messages.

Primary Outcome

Patient body weight in kilograms will be obtained by clinical staff on hospital approved and calibrated electronic standing scales. The patient's body weight will be collected from the patient's electronic medical record.

Interventions

  • BEHAVIORAL Health Coaching

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2026-10-01
Est. Completion 2028-10-01
Phase NA
Ohio State University

552 total trials

What is known before NCT06904144 opens enrollment

NCT06904144 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Health Coaching is the first listed.

NCT06904144 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06904144 about?

NCT06904144 is a clinical study titled "Health Coaching for Patients With Cardiovascular Disease". For patients discharged with a diagnosis of cardiovascular disease coronary artery disease resulting in myocardial infarction and/or congestive heart failure, this study will evaluate if the addition of 12 virtual health coaching sessions over the course of 16 weeks will improve physiological, psych...

What is the current status of trial NCT06904144?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2026-10-01. Estimated completion is 2028-10-01.

What interventions are being tested in trial NCT06904144?

The interventions under investigation include: Health Coaching (BEHAVIORAL).

Who is sponsoring clinical trial NCT06904144?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06904144's enrollment target sits among peer trials

70 1103rd of 2000 higher than 868 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06904144, the US trial registry maintained by the National Library of Medicine. NCT06904144 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.